- Home
- ELVN vs IRMD Comparison
ELVN vs IRMD Comparison
Compare ELVN & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | IRMD |
|---|---|---|
| Founded | 2016 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 910.4M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ELVN | IRMD |
|---|---|---|
| Price | $21.00 | $92.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $41.20 | ★ $72.00 |
| AVG Volume (30 Days) | ★ 486.5K | 69.2K |
| Earning Date | 11-12-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 0.72% |
| EPS Growth | N/A | ★ 13.00 |
| EPS | N/A | ★ 1.65 |
| Revenue | N/A | ★ $80,511,268.00 |
| Revenue This Year | N/A | $15.17 |
| Revenue Next Year | $20.05 | $10.15 |
| P/E Ratio | ★ N/A | $56.91 |
| Revenue Growth | N/A | ★ 12.91 |
| 52 Week Low | $13.30 | $47.48 |
| 52 Week High | $25.96 | $94.74 |
Technical Indicators
Market Signals| Indicator | ELVN | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.08 | 72.77 |
| Support Level | $19.58 | $91.46 |
| Resistance Level | $22.14 | $94.74 |
| Average True Range (ATR) | 1.28 | 2.11 |
| MACD | -0.06 | 0.09 |
| Stochastic Oscillator | 41.37 | 85.62 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.